Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes: later-stage trial registry
86 of 342 indexed Diabetes trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #19 of 28,707 conditions by registered trial count.
342 US clinical trials · 86 currently recruiting · #19 of 28,707 conditions by registered trial count
Diabetes: 342 US clinical trials tracked, 86 recruiting.
Diabetes is the subject of 342 registered US clinical trials on ClinicalTrials.gov, 86 of them currently open to new participants. 55 are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 41 of these trials.
Enrollment posture brief
Registry condition diabetes
OPEN 86 | RECR 25% | LATE 55 | EARLY 36 | RANK #19 | SPON 41
Volume-matched condition peers
Nearest open-share peer: Low Back Pain (25% recruiting · 123 trials)
Diabetes lists 86 open slots (25% of 342 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes is recruiting below its size-band peers.
86 of 342 indexed trials (25.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes trials is spread across many organizations.
Novo Nordisk A/S accounts for 41 of 342 trials (12%). 161 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes enrolment sits around 150 participants.
Median target enrolment is 150 among the 339 trials that report a genuine target (sentinel values excluded). 144 of those (42.5%) plan for fewer than 100 participants.
-
Diabetes research is mostly interventional.
263 interventional and 79 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
342 total, page 7 of 7
Nonvisual Foot Inspection for People With Visual Impairment
Case Western Reserve University
NCT01822717
High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script
University of California, San Diego
NCT03049592
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Veterans Medical Research Foundation
NCT00895921
Periodontal and Periapical Inflammation and Pregnancy
Roger Johnson
NCT00490165
Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program
University of Pittsburgh
NCT00867425
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
Wockhardt
NCT00752180
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Novo Nordisk A/S
NCT00065130
A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain
TheraVasc
NCT02412852
N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes
City of Hope Medical Center
NCT02065310
Diabetes Education and Care for Deaf Populations
University of Utah
NCT06577506
Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension
InVasc Therapeutics
NCT00795262
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
Children's Mercy Hospital Kansas City
NCT00511030
Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
University of Chicago
NCT00915707
Free Test Strips and Blood Glucose Control
University of Wisconsin, Madison
NCT00205335
Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery
The Cleveland Clinic
NCT00488423
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
NatureGen
NCT00262145
Depression-Diabetes Mechanisms: Urban African Americans
Emory University
NCT00209170
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
Novo Nordisk A/S
NCT01511185
Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg
University of California, San Diego
NCT01804478
Adjusting Insulin Delivery to Activity
Boston Children's Hospital
NCT02299479
Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT01419535
Insulin Secretion in Diabetes Before and After Glycemic Control
US Department of Veterans Affairs
NCT00469833
Mitochondrial Dysfunction in Diabetes
Mayo Clinic
NCT01724502
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
Hartford Hospital
NCT02620774
Barley Beta-glucan, Glycemic Control, and Appetite
Washington State University
NCT06146322
Glucose Measurement Using Microneedle Patches
Emory University
NCT02682056
Fructose-Induced Palmitate Synthesis in Overweight Subjects
Rockefeller University
NCT00535535
Evaluation of a Non-invasive Brain Compliance Measurement Device
Stanford University
NCT01753921
HOPE Pilot for Veterans With Complex Diabetes
Michael E. DeBakey VA Medical Center
NCT01274715
A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling
The University of Texas Health Science Center at San Antonio
NCT01740817
FFA Hypertension and Inflammation in Lean and Obese Subjects
Emory University
NCT00721617
Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent
The University of Texas Medical Branch, Galveston
NCT04602650
Implementation of a Cardiometabolic Disease Staging System in Primary Care
University of Alabama at Birmingham
NCT04922294
Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
Children's Hospital of Philadelphia
NCT03303196
Intestinal Sweet Taste Receptor Function and Adaptation to Dietary Sugars and Sweeteners
AdventHealth Translational Research Institute
NCT02835859
A Study to Evaluate Glucose and Insulin Response to Nutralin
Avera McKennan Hospital & University Health Center
NCT01275820
The Mobile Health Platform
Duke University
NCT02099513
RBC Lifespan Measurement in Diabetic Children
Guohua An
NCT03073070
Novel Therapies for Metabolic Complications of Lipodystrophies
University of Texas Southwestern Medical Center
NCT00457938
Effects of Human Leptin Replacement
University of Miami
NCT00657605
Examining Macrophage Influx and Vascularization in Chronic Pancreatitis
University of Colorado, Denver
NCT00491023
Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans
US Department of Veterans Affairs
NCT00018486
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 13 |
| Phase 3 | 37 |
| Phase 4 | 18 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes page
342 registered trials, 86 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 86 Diabetes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Diabetes trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes condition card totals 342 registered trials; most-linked intervention insulin degludec; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.